Article
Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
Molecular cancer - 14 Apr 2017
Di Meo Ashley, Bartlett Jenni, Cheng Yufeng, Pasic Maria D, Yousef George M
Abstract excerpt
There is a growing trend towards exploring the use of a minimally invasive "liquid biopsy" to identify biomarkers in a number of cancers, including urologic malignancies. Multiple aspects can be assessed in circulating cell-free DNA, including cell-free DNA levels, integrity, methylation and mutations. Other prospective liquid biopsy markers include circulating tumor cells, circulating RNAs (miRNA, lncRNAs and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
